Clinical Trial Update: Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)

View source ↗

Summary

A non-interventional study evaluating oral vinorelbine in patients with advanced non-small cell lung cancer and metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Vinorelbine (oral) (Vinorelbine)

Snippet

Sponsor: Pierre Fabre Pharma GmbH | Conditions: Non Small Cell Lung Carcinoma, Metastatic Breast Cancer | Status: COMPLETED